Overview

• Sanofi has been indicted for environmental infractions linked to toxic emissions from its Mourenx factory in France between 1978 and 2018.
• The charges include obstruction of an environmental inspection, operating without adhering to regulations, and failure to report incidents.
• The company avoided the more severe charge of endangering lives and is currently classified as an assisted witness for this accusation.
• Investigations revealed emissions of valproate of sodium, the active ingredient in Dépakine, at levels far exceeding safety standards, with concerns about health impacts on workers and nearby residents.
• At least 15 residents, alleging health issues similar to Dépakine exposure, have joined the case as civil parties, supported by advocacy groups and unions.